Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets - Hagens Berman
Zoetis Inc. Class A (ZTS)
Last zoetis inc. class a earnings: 2/13 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zoetis.com
Company Research
Source: GlobeNewswire
SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman, a prominent national trial law firm, is urging investors who suffered substantial losses in Zoetis Inc. (NYSE: ZTS) to promptly report their losses here. Additionally, individuals with relevant knowledge who may assist in the investigation are encouraged to contact the firm’s attorneys. Website: www.hbsslaw.com/investor-fraud/ZTS Contact An Attorney Now: ZTS@hbsslaw.com Phone: 844-916-0895 Zoetis Inc. (ZTS) Investigation: The investigation centers around Zoetis’ arthritis drugs, specifically Librela™ and Solensia™, which are designed to alleviate painful osteoarthritis in dogs and cats, respectively. Historically, these products have been significant revenue drivers for Zoetis’ companion animal division, with the company projecting peak sales of over $1 billion for its osteoarthritis pain franchise. However, a Wall Street Journal article published on Apr. 12, 2024 titled “What Killed Their Pets? Owners Blame Meds,
Show less
Read more
Impact Snapshot
Event Time:
ZTS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZTS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZTS alerts
High impacting Zoetis Inc. Class A news events
Weekly update
A roundup of the hottest topics
ZTS
News
- IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the FirmAccesswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTSPR Newswire
- Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets – Hagens BermanGlobeNewswire
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zoetis Inc. and Encourages Investors with Losses to Contact the FirmAccesswire
- Zoetis to Participate in the Stifel 2024 Jaws and Paws Conference Business Wire
ZTS
Earnings
- 5/2/24 - Beat
ZTS
Sec Filings
- 5/8/24 - Form DEFA14A
- 5/7/24 - Form 144
- 5/6/24 - Form DEFA14A
- ZTS's page on the SEC website